Martin Stangel Selected Research

Autoimmune Diseases of the Nervous System

11/2021	Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis.
1/2020	Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.
1/2019	Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis Under Immunosuppression After Liver Transplantation.
10/2015	Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA receptor encephalitis.
6/2014	Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Stangel Research Topics

Disease

63	Multiple Sclerosis 01/2023 - 09/2002
38	Demyelinating Diseases (Demyelinating Disease) 11/2023 - 11/2003
13	Relapsing-Remitting Multiple Sclerosis 09/2019 - 03/2008
12	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 07/2012
12	Infections 11/2021 - 01/2012
11	Inflammation (Inflammations) 01/2023 - 09/2008
10	Neuroinflammatory Diseases 11/2023 - 03/2014
8	Neoplasms (Cancer) 01/2021 - 10/2015
6	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 12/2021 - 01/2013
6	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2007
6	Progressive Multifocal Leukoencephalopathy 01/2021 - 12/2014
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 09/2008
5	Central Nervous System Diseases (CNS Diseases) 01/2022 - 11/2003
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 01/2012
5	Autoimmune Diseases of the Nervous System 11/2021 - 06/2014
5	Herpes Zoster 01/2020 - 01/2014
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2003
5	Guillain-Barre Syndrome 01/2013 - 09/2006
4	Central Nervous System Viral Diseases 11/2023 - 01/2019
4	COVID-19 01/2022 - 01/2020
4	Meningitis 01/2021 - 01/2019
4	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2021 - 09/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2013 - 01/2011
4	Dermatomyositis (Dermatopolymyositis) 09/2008 - 09/2006
3	Virus Diseases (Viral Diseases) 11/2023 - 03/2015
3	Central Nervous System Infections (Central Nervous System Infection) 11/2021 - 01/2014
3	Vesicular Stomatitis 01/2021 - 03/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2019
3	Glioma (Gliomas) 01/2021 - 06/2014
3	Encephalomyelitis (Myeloencephalitis) 01/2021 - 11/2014
3	Tourette Syndrome (Tourette's Syndrome) 01/2020 - 10/2015
3	Bell Palsy (Bell's Palsy) 01/2020 - 01/2018
3	Disease Progression 01/2019 - 09/2008
3	Gliosis 10/2014 - 08/2009
3	Stiff-Person Syndrome (Stiff Man Syndrome) 09/2008 - 01/2007
2	Herpes Simplex Encephalitis (Herpes Encephalitis) 12/2021 - 01/2020
2	Viral Encephalitis 10/2021 - 10/2018
2	Viral Meningitis 01/2021 - 01/2020
2	Bacterial Meningitis 01/2021 - 01/2020
2	Normal Pressure Hydrocephalus 01/2020 - 01/2019
2	Lymphopenia (Lymphocytopenia) 01/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Neuroblastoma 01/2019 - 08/2013
2	Seizures (Absence Seizure) 01/2019 - 04/2008
2	Chickenpox 01/2019 - 01/2014

Drug/Important Bio-Agent (IBA)

33	CuprizoneIBA 11/2023 - 12/2007
13	Immunoglobulin G (IgG)IBA 11/2023 - 09/2010
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2014
12	AntibodiesIBA 01/2022 - 01/2011
10	Oligoclonal BandsIBA 01/2022 - 01/2012
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
10	Natalizumab (Tysabri)FDA Link 10/2020 - 09/2006
9	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 09/2006
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 09/2002
7	AutoantibodiesIBA 01/2022 - 01/2009
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2013
6	Interferon-betaIBA 07/2016 - 08/2006
4	CytokinesIBA 01/2022 - 12/2007
4	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2021 - 01/2019
4	Cladribine FDA LinkGeneric 09/2021 - 12/2012
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2019
4	Dimethyl FumarateIBA 01/2020 - 07/2013
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2011
3	Phospholipids (Phosphatides)FDA LinkGeneric 11/2023 - 01/2020
3	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2023 - 04/2017
3	KynurenineIBA 12/2021 - 01/2019
3	Cytidine Diphosphate Choline (Citicoline)IBA 11/2021 - 05/2013
3	Methylprednisolone FDA LinkGeneric 10/2020 - 05/2018
3	teriflunomideIBA 10/2020 - 09/2016
3	Alemtuzumab (Campath)FDA Link 01/2020 - 05/2018
3	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2014
3	Glatiramer Acetate (Copaxone)FDA Link 01/2020 - 09/2011
3	N-Methylaspartate (NMDA)IBA 01/2019 - 06/2014
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019 - 01/2011
3	AntigensIBA 08/2018 - 01/2009
3	CopperIBA 05/2017 - 12/2007
3	Chelating AgentsIBA 05/2017 - 12/2007
3	Fingolimod Hydrochloride (FTY720)FDA Link 12/2016 - 06/2014
3	LipopolysaccharidesIBA 10/2015 - 11/2011
3	Messenger RNA (mRNA)IBA 10/2014 - 01/2011
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2014 - 01/2011
2	LigandsIBA 11/2023 - 10/2015
2	polysialic acidIBA 01/2023 - 01/2017
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 02/2015
2	CytidineIBA 11/2021 - 05/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2021 - 01/2021
2	IpilimumabIBA 01/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2008
2	InterferonsIBA 01/2020 - 11/2010
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 12/2019 - 10/2015
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2019 - 01/2010
2	IntegrinsIBA 01/2019 - 10/2017
2	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2018 - 03/2015

Therapy/Procedure

25	Therapeutics 11/2021 - 09/2006
5	Immunotherapy 01/2021 - 03/2011
3	Plasma Exchange 11/2018 - 01/2009
2	Hematopoietic Stem Cell Transplantation 01/2021 - 06/2009
2	Transplantation 01/2019 - 05/2018